Berberine
A plant alkaloid studied for blood sugar and lipid control in type 2 diabetes.
Supplements
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Berberine
A plant alkaloid studied for blood sugar and lipid control in type 2 diabetes.
Evidence category: Systematic review. This describes the source category, not approval or certainty.
Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.
Berberine is a plant alkaloid found in Berberis and related species with a long history of use in traditional Chinese and Ayurvedic medicine. It has been studied mainly in people with type 2 diabetes for effects on glucose and lipid metabolism, most often as an addition to standard diabetes therapy rather than in place of it.
Benefits reported in the imported source
- Consistent reductions in blood glucose markers across pooled trials
- Improvements in lipid profile alongside glucose effects
- Appears effective as an addition to standard diabetes therapy in pooled analysis
Risks and limits
- Most underlying trials were conducted in China with variable reporting quality
- Gastrointestinal side effects are commonly reported
- Long-term safety data outside trial settings are limited
Source bottom line: Pooled trial evidence for glucose and lipid effects is consistent, but the geographic concentration and quality of underlying trials warrant a cautious reading pending independent replication.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
Adults with type 2 diabetes across forty-six randomized controlled trials, most conducted in China
- Reported regimen
- Berberine administered alone or combined with standard glucose-lowering or lipid-lowering therapy, compared with control groups, across trials of varying dose and duration
- Duration
- Trials of varying duration, pooled across forty-six studies
- Reported outcome
- Significant reductions in HbA1c, fasting and post-meal glucose, triglycerides, total cholesterol and LDL cholesterol, alongside an increase in HDL cholesterol, versus control
- Source
- The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed
Claim provenance
evidence.json#/catalog:supplement:berberine/protocols/0
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Unverified imported account — Berberine | Memorial Sloan Kettering Cancer Center - About Herbs
An imported authored paraphrase, not a quotation or a recommended protocol.
Review: unverified historical account. The imported wording is preserved for attribution; its full clinical, dosing, efficacy or consensus claims have not been independently established. Unvalidated source account; no validated human dosing population or animal-to-human equivalence is inferred.
Imported wording: Memorial Sloan Kettering's reference describes berberine-containing plants used in traditional Chinese medicine and Ayurveda; this records traditional use, not established clinical benefit.
Berberine | Memorial Sloan Kettering Cancer Center - About Herbs
Historical research outcome: verified-description · 2026-10-06
An attributed practice description was verified without importing the source's benefit claims, recommendations or assumptions about prevalence.
- https://www.mskcc.org/cancer-care/integrative-medicine/herbs/berberine: verified-description — Independently read the live source and checked this limited, attributed description: Memorial Sloan Kettering's reference describes berberine-containing plants used in traditional Chinese medicine and Ayurveda; this records traditional use, not established clinical benefit.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
Snapshot provenance
Source ID: catalog:supplement:berberine. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.